Cargando…
Predicting Treatment Outcomes: The Case for Hypoxia Gene Signatures
Autor principal: | Marignol, Laure |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020707/ https://www.ncbi.nlm.nih.gov/pubmed/29776747 http://dx.doi.org/10.1016/j.ebiom.2018.05.016 |
Ejemplares similares
-
Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?
por: Iwamoto, Takayuki, et al.
Publicado: (2010) -
Ferroptosis gene signature in cholangiocarcinoma
por: Cingaram, Pradeep Reddy
Publicado: (2022) -
Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells
por: Meunier, Armelle, et al.
Publicado: (2016) -
Pro-con of proton: Dosimetric advantages of intensity-modulation over passive scatter for thoracic malignancies
por: Jie, Ang Wei, et al.
Publicado: (2020) -
Hypoxia therapy--a new hope for the treatment of mitochondrial dysfunctions
por: Huang, Jun-long, et al.
Publicado: (2016)